Erin D. Gordon
- University of California, San Francisco · Internal Medicine (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #5,100
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9763668Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2026 onlyCareer claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2026
Linked Award Amount
$3.4M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#5,100
By linked amount among FY2026 PIs
Earliest Year Loaded
2026
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2026): $3.4M in linked award amounts across 2 award records · Award-linked rank #5100.
FY2026 award records by amount
NIH award records listing Erin D. Gordon as a PI. Multi-PI records show the full award amount for context.
- 1R01HL185359-01R01Contact PIGenetic and Molecular Mechanisms of PGE2-EP4-Induced Goblet Cell Metaplasia in AsthmaUniversity of California, San Francisco · Internal Medicine (NIH department code)$3.2Maward amount
- 1R03AI190673-01A1R03Contact PIDevelopment of a Humanized IL33 MouseUniversity of California, San Francisco · Internal Medicine (NIH department code)$174.8Kaward amount
Award organization
Organizations that administered FY2026 awards listing Erin D. Gordon as a PI.
FY2026 award administered by University of California, San Francisco (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2026First NIH AwardUniversity of California, San Francisco
- 2026$500K Cumulative Funding
- 2026$1M Cumulative Funding
- 2026$2M Cumulative Funding
- 2026Entered Top 50% NationallyRanked #5100